Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Dara M. FitzGerald"'
Autor:
Kieran Sheahan, Mairin Rafferty, Paul Donnellan, Elaine W. Kay, Owen MacEneaney, Derek G. Power, Julie Moran, Stephen P. Finn, Allan O'Keeffe, John Crown, Karin van den Hurk, Ian G. Murphy, Michelle Murphy, Balázs Bálint, Zsolt Orosz, Cynthia Heffron, Patrick O’Leary, William M. Gallagher, Joost van den Oord, Sinead Toomey, Clodagh M. McDermott, Cathal O'Brien, Louise Unwin, Padraic J. Regan, Ruben Yela, Dara M. FitzGerald, Robert Cummins, Enda W. McDermott, Bryan T. Hennessy
Publikováno v:
Melanoma Research, 25(3), 189-199. LIPPINCOTT WILLIAMS & WILKINS
Because of advances in targeted therapies, the clinical evaluation of cutaneous melanoma is increasingly based on a combination of traditional histopathology and molecular pathology. Therefore, it is necessary to expand our knowledge of the molecular
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::972ca0c773d198beee7caed45905902a
https://doi.org/10.1097/cmr.0000000000000149
https://doi.org/10.1097/cmr.0000000000000149
Autor:
Robert Cummins, Cecily Quinn, Etáin Daly, Aisling Pierce, Michael J. Duffy, Elaine W. Kay, Yue Fan, Mairin Rafferty, Dara M. FitzGerald, Miriam A Lynn, Fredrik Pontén, Louise Flanagan, Anthony O'Grady, Gillian O'Hurley, Karin Jirström, William M. Gallagher
Publikováno v:
Histopathology. 64:660-670
Aims Triple-negative breast cancer (TNBC) is responsible for a disproportionate number of breast cancer (BC) deaths, owing to its intrinsic aggressiveness and a lack of treatment options, especially targeted therapies. Thus, there is an urgent need f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::59e97c5ed864bbaf8b9d1afb27c17eb3
https://doi.org/10.1111/his.12313
https://doi.org/10.1111/his.12313